Summary
This systematic review examines mesenchymal stem cells as a treatment for polycystic ovary syndrome, focusing on inflammation markers. This paper has no relevance to lighting design, circadian health, or any of the specified categories.
Author(s)
GD Prayitno, K Lestari, CR Sartika, T Djuwantono
Publication Year
2022
Number of Citations
5